ИСПОЛЬЗОВАНИЕ БИОРЕГУЛЯЦИОННОГО ЭУФОРБИУМ КОМПОЗИТУМ® НАЗЕНТРОПФЕН С В ЛЕЧЕНИИ ОСТРЫХ ПАРАНАЗАЛЬНЫХ СИНУСИТОВ

Abstract

Acute sinusitis is an acute inflammation of the mucous membrane of the paranasal sinuses of an infectious (viral, bacterial, fungal), allergic, traumatic or mixed nature, characterized by a predominance of edematous infiltrative changes and the presence of a serous, mucous, purulent, hemorrhagic, fibrinous or mixed exudate core in the sinuses (sinus). In children, sinusitis complicates up to 5% of upper respiratory tract infections. By referring to the ENT department of medical institutions, patients with diseases of the paranasal sinuses (SNPS) are the dominant group and account for 62%. During the period from 03.04.2019 to 04.25.2019, in the clinic “21st Century», 30 (100%) patients of 10 men and 20 women aged from 23 to 40 years with acute paranasal sinusitis were treated.All patients underwent diagnostic screening in the amount of (general inspection of ENT-organs,general blood test, x-ray of the paranasal sinuses, where the total darkening of the maxillary sinuses was noted$ the pneumatisation of the remaining sinuses was not affected)All patients voluntarily refused the puncture treatment. Treatment: systemic antimicrobial therapy, detoxification therapy, decongestants, topical steroids, antihistamines According to our research, the following conclusions were formed: In the complex therapy of acute paranasal sinusitis with the use of the herbal medicine Euphorbium Compositum, recovery of pneumonization of SNPs was observed on day 7 of treatment - 6 (60%) patients, in 4 (40%) there was a decrease in pneumatization of SNPs by the type of parietal - edematous processes without signs of a fluid component in enlighten sunusa. Reduction of the symptom of nasal obstruction on the 3rd day of complex treatment - 7 (70%). Preservation of the symptoms of nasal obstruction - 3 (30%) patients on the 7th day of treatment - 10 (100%) patients.